Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Quackeron Aug 15, 2022 5:53pm
309 Views
Post# 34897784

Financing

FinancingIf there is financing that is needed there are two options: 1. Go to the Bank and get a Line of credit using the contracts from ARC and Dept of Veterans. 2. Go to the more likely source Baxter and ask them to give their 2nd tranche a little earlier. We have signed a contract with them and now seeing what Dialco has done with Arc and Veteran 's Dept, it might be to their benefit. If there is a financing coming out in the way of warrants, first right should go out to the existing shareholders (we have kept the company a float for all these years). l would love to see a Shareholder Ombudsman selected to sit on the Board and responsible for sitting on the Compensation Committee in charge of looking at Management Compensation. Also, should be in charge of shareholder updates. I invested in this company as they were looking to get rid of sepsis in North America and still believe we are on the right track. I remember the cardiac discovery so you know I am a Long.
<< Previous
Bullboard Posts
Next >>